#United States #Miami #Quest Diagnostics #Global Healthcare #Sam Samad

Quest Diagnostics to Showcase Innovations at Citi's 2025 Global Healthcare Conference

On December 2, 2025, at 3:15 PM ET, Sam Samad, the Executive Vice President and Chief Financial Officer of Quest Diagnostics Incorporated (NYSE: DGX), will participate in a discussion at Citi's 2025 Global Healthcare Conference in Miami. This conference is anticipated to provide valuable insights into the healthcare sector, focusing on the latest strategies, company performance, and ongoing market trends.

This event serves as an essential platform for industry leaders to engage in discussions that shape the future of healthcare. During the fireside chat, participants can expect to hear from Samad about how Quest Diagnostics remains a trailblazer in diagnostic information services. With a wealth of experience, he is set to highlight how the company is leveraging its substantial resources to respond to the evolving demands of healthcare.

Quest Diagnostics, recognized for its leading position in the healthcare ecosystem, operates with a mission to enhance health outcomes through advanced diagnostic insights. The company handles laboratory testing, which serves as a foundation for clinical decision-making for healthcare providers across the United States. They aim to empower individuals and organizations with actionable data derived from one of the world's most extensive databases of clinical lab results.

The conference will also be webcast live on Quest Diagnostics’ investor relations page, ensuring that interested parties can access the information regardless of their attendance. For those unable to tune in live, the recorded session will be available within 24 hours after the event and will remain accessible until January 2, 2026. By making these discussions available to a broader audience, Quest Diagnostics demonstrates its commitment to transparency and engagement with stakeholders.

As a cornerstone in healthcare diagnostics, Quest Diagnostics caters to approximately one in three adult Americans annually and partners with half of the nation's physicians and hospitals. The company’s impressive scale and robust workforce, comprising over 55,000 employees, allow for a deep understanding of how diagnostic insights can catalyze significant improvements in health management.

Moreover, the ongoing emphasis on innovation and research at Quest Diagnostics enables the organization to continuously evolve its services. The ability to identify and treat diseases early, particularly through commercialized tests and cutting-edge technologies, positions the company to drastically alter healthcare outcomes positively.

As anticipation builds toward the conference, healthcare professionals, investors, and industry observers alike are eager to learn about the strategic directions that Quest Diagnostics will take under Samad's insight. This session at Citi's healthcare conference is more than just a talk; it is an opportunity to glimpse into the future of healthcare solutions that can potentially affect millions of lives.

For the latest updates on the event and insights immediate to Quest Diagnostics, stakeholders are encouraged to visit Quest Diagnostics’ official website or the investor relations section for real-time updates and information.

With healthcare constantly evolving, events like these are crucial for keeping the dialogue open between healthcare innovators and the public, making it an exciting time for all involved in the sector.